Skip to content
CEpartner4U
  • Welcome
  • About us
    • Team
    • Jobs
  • Services
    • AR/EC Rep
    • Regulatory affairs
    • Quality system
    • CE/QMS Entry Packages©
    • Clinical evaluation
    • Training
  • UKCApartner4U
  • Information
    • F.A.Q. AR/EC Rep
    • Links
  • Library
  • News
  • Network
  • Contact

About:m.vandervoort

Posts by m.vandervoort :

  • Notice to manufacturers to ensure timely compliance with MDR requirements, 29 November 2023 in Uncategorized
  • Regulation (EU) 2023/2197 on assignment of UDIs for contact lenses published, 20 October 2023 in Uncategorized
  • MDCG 2023-4 Medical Device Software (MDSW) – Hardware combinations, 18 October 2023 in Uncategorized
  • European Commission published Q&A on MDR Annex XVI, 26 September 2023 in Uncategorized
  • IMDRF: Personalized Medical Devices – Regulatory Pathways, 19 September 2023 in Uncategorized
  • TEAM-NB: Tripartite agreement between manufacturer, outgoing MDD-NB and incoming MDR-NB, 24 August 2023 in Uncategorized
  • Newly released flowchart to assist in deciding whether or not a device is covered by the extended MDR transitional period, 23 August 2023 in Uncategorized
  • MHRA published infographic on timelines for placing CE marked IVDs and medical devices on the Great Britain market, 27 July 2023 in Uncategorized
  • Notified Body confirmation letters in the framework of Regulation (EU) 2023/607 and (EU) 2024/1860, 26 July 2023 in Uncategorized
  • Q&A published on MDR extension (Regulation (EU)2023/607), 18 July 2023 in Uncategorized
  • «
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 12
  • »

Stay informed

Please check your inbox or spam box to confirm

Copyright 2026 CEpartner4U | Esdoornlaan 13 | 3951 DB Maarn | The Netherlands | +31.6.516.536.26 | office@cepartner4u.com
  • enEnglish